Liquid Amies Media Ensures Reliable Clinical Specimen Transport

2026-01-26 - Leave me a message

In modern clinical microbiology, specimen integrity during transport is critical for accurate diagnosis and timely treatment. As laboratories across Europe and North America continue to emphasize standardized pre-analytical workflows, Liquid Amies Transport Media remains a trusted solution for preserving bacterial viability from collection to analysis.

BABIO (Babio Biotechnology), a well-known Chinese manufacturer of microbiological and IVD consumables, offers ready-to-use Liquid Amies Media designed for the collection, transport, and preservation of clinical specimens. The non-nutritive formulation helps prevent overgrowth while maintaining organism survival, making it ideal for routine bacteriological testing.

Formulated with thioglycolate to reduce redox potential, phosphate buffer for pH stability, and sodium chloride for osmotic balance, Liquid Amies Media supports the survival of a wide range of aerobic and facultative microorganisms for 24–48 hours under recommended conditions. It is particularly suitable for use with swab-based specimens collected from the throat, wound, urogenital tract, and other sites.

BABIO Liquid Amies Media is available in multiple fill volumes (1–6 ml) and flexible packaging options, supporting hospitals, diagnostic laboratories, public health institutions, and sample collection programs. With controlled storage stability and bulk supply capability, BABIO helps global partners maintain consistent testing quality and logistics efficiency.

To learn more about Liquid Amies Media specifications, packaging options, and related transport solutions, visit the official BABIO website: https://www.babiocorp.com

#LiquidAmies
#TransportMedia
#ClinicalMicrobiology
#SpecimenTransport
#IVD
#DiagnosticTesting
#MedicalConsumables
#BABIO

Send Inquiry

  • E-mail
  • QR
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy